COMMUNIQUÉS West-GlobeNewswire

Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
20/09/2024
Experienced Life Sciences Executive Brings Strategic Expertise to Support Traws’ Further Transformation and Growth Director James J Marino Also to Step Down from Traws Board After a Decade of Service NEWTOWN, Pa., Sept [...]
Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study
20/09/2024
Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study Data presented at ECTRIMS show that tolebrutinib, a [...]
CP : Le tolebrutinib a permis d’allonger de 31 % le délai avant progression confirmée du handicap dans le cadre d’une étude de phase III menée chez des personnes présentant une sclérose en plaques secondairement progressive non active
20/09/2024
Le tolebrutinib a permis d’allonger de 31 % le délai avant progression confirmée du handicap dans le cadre d’une étude de phase III menée chez des personnes présentant une sclérose en plaques secondairement progressive [...]
Inbiome, developing a new PCR technology capable of simultaneous identification of hundreds of bacterial pathogens in a single test, welcomes Professor Dr. Carl Wittwer to its Advisory Board
20/09/2024
Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics, today announced the appointment of Professor Dr. Carl Wittwer ( picture ), a global authority in PCR technology and [...]
Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination
20/09/2024
WALTHAM, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has [...]
213,285 Orion Corporation A shares converted into B shares
20/09/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 SEPTEMBER 2024 at 9.30 EEST 213,285 Orion Corporation A shares converted into B shares In accordance with [...]
Financière de Tubize - Transparency notification
20/09/2024
Publication concerning a transparency notification (article 14, first paragraph of the law of 2 May 2007 concerning the publication of significant participating interests) Press release - Regulated information Brussels [...]
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
19/09/2024
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
ADR Ratio Change
19/09/2024
September 19, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a [...]
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
19/09/2024
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization [...]
GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
19/09/2024
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen’s Iqirvo® (elafibranor) in the U.S. for [...]
GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société
19/09/2024
Trésorerie et équivalents de trésorerie s’éle vant à 61,6 m illio ns d’euros au 30 juin 2024 n’incluant pas le paiement d’étape de 48,7 millions d’euros facturé en juin 2024 (reçu en août 2024) lors de la première vente [...]
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
19/09/2024
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to commence in the first [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/09/2024
SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
19/09/2024
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the American Heart [...]
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
19/09/2024
Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants Altamira [...]
Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
19/09/2024
Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cytokinetics [...]
Rejuveron Life Sciences AG prend le nom de Centenara Labs AG et fait le point sur les dernières données cliniques
19/09/2024
Les actionnaires approuvent le changement de dénomination sociale sous la marque Centenara Labs AG (« Centenara ») Le changement de marque positionne l’entreprise pour des initiatives stratégiques destinées à soutenir [...]
EON Medical & Wellness: Transforming Healthcare for the Hispanic Community Through Cutting-Edge Telehealth
19/09/2024
Revolutionizing Healthcare Access with Culturally Focused, Language-Accessible Care TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- EON Medical + Wellness , a pioneering force in healthcare, is making waves in the [...]

Pages